3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Breast percent density changes in digital mammography pre‐ and post‐radiotherapy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Breast cancer (BC), the most frequently diagnosed malignancy among women worldwide, presents a public health challenge and affects mortality rates. Breast‐conserving therapy (BCT) is a common treatment, but the risk from residual disease necessitates radiotherapy. Digital mammography monitors treatment response by identifying post‐operative and radiotherapy tissue alterations, but accurate assessment of mammographic density remains a challenge. This study used OpenBreast to measure percent density (PD), offering insights into changes in mammographic density before and after BCT with radiation therapy.

          Methods

          This retrospective analysis included 92 female patients with BC who underwent BCT, chemotherapy, and radiotherapy, excluding those who received hormonal therapy or bilateral BCT. Percent/percentage density measurements were extracted using OpenBreast, an automated software that applies computational techniques to density analyses. Data were analysed at baseline, 3 months, and 15 months post‐treatment using standardised mean difference (SMD) with Cohen's d, chi‐square, and paired sample t‐tests. The predictive power of PD changes for BC was measured based on the receiver operating characteristic (ROC) curve analysis.

          Results

          The mean age was 53.2 years. There were no significant differences in PD between the periods. Standardised mean difference analysis revealed no significant changes in the SMD for PD before treatment compared with 3‐ and 15‐months post‐treatment. Although PD increased numerically after radiotherapy, ROC analysis revealed optimal sensitivity at 15 months post‐treatment for detecting changes in breast density.

          Conclusions

          This study utilised an automated breast density segmentation tool to assess the changes in mammographic density before and after BC treatment. No significant differences in the density were observed during the short‐term follow‐up period. However, the results suggest that quantitative density assessment could be valuable for long‐term monitoring of treatment effects. The study underscores the necessity for larger and longitudinal studies to accurately measure and validate the effectiveness of quantitative methods in clinical BC management.

          Abstract

          This study used OpenBreast software to analyse digital mammograms and quantitatively evaluate changes in breast percent density (PD) in women with breast cancer before and after radiotherapy, and at 3 and 15 months post‐treatment. These findings suggest that breast density continues to evolve over the first year following radiotherapy, highlighting the need for further research.

          Related collections

          Most cited references46

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Current and future burden of breast cancer: Global statistics for 2020 and 2040

          Background Breast cancer is the most commonly diagnosed cancer worldwide, and its burden has been rising over the past decades. In this article, we examine and describe the global burden of breast cancer in 2020 and predictions for the year 2040. Methods Estimates of new female breast cancer cases and deaths in 2020 were abstracted from the GLOBOCAN database. Age-standardized incidence and mortality rates were calculated per 100,000 females by country, world region, and level of human development. Predicted cases and deaths were computed based on global demographic projections for the year 2040. Results Over 2.3 million new cases and 685,000 deaths from breast cancer occurred in 2020. Large geographic variation across countries and world regions exists, with incidence rates ranging from <40 per 100,000 females in some Asian and African countries, to over 80 per 100,000 in Australia/New Zealand, Northern America, and parts of Europe. Smaller geographical variation was observed for mortality; however, transitioning countries continue to carry a disproportionate share of breast cancer deaths relative to transitioned countries. By 2040, the burden from breast cancer is predicted to increase to over 3 million new cases and 1 million deaths every year because of population growth and ageing alone. Conclusion Breast cancer is the most common cancer worldwide and continues to have a large impact on the global number of cancer deaths. Global efforts are needed to counteract its growing burden, especially in transitioning countries where incidence is rising rapidly, and mortality rates remain high. • With over 2.3 million new cases and 685,000 deaths in 2020, breast cancer is the most commonly diagnosed cancer worldwide. • Most cases occur in transitioned countries yet transitioning countries have disproportionate share of breast cancer deaths. • The future burden of breast cancer is predicted to increase to over 3 million new cases and 1 million deaths in 2040.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020

            Background Breast cancer is the most commonly diagnosed cancer and leading cause of cancer death among women worldwide but has patterns and trends which vary in different countries. This study aimed to evaluate the global patterns of breast cancer incidence and mortality and analyze its temporal trends for breast cancer prevention and control. Methods Breast cancer incidence and mortality data in 2020 were obtained from the GLOBOCAN online database. Continued data from the Cancer Incidence in Five Continents Time Trends, the International Agency for Research on cancer mortality and China National Central Cancer Registry were used to analyze the time trends from 2000 to 2015 through Joinpoint regression, and annual average percent changes of breast cancer incidence and mortality were calculated. Association between Human Development Index and breast cancer incidence and mortality were estimated by linear regression. Results There were approximately 2.3 million new breast cancer cases and 685,000 breast cancer deaths worldwide in 2020. Its incidence and mortality varied among countries, with the age‐standardized incidence ranging from the highest of 112.3 per 100,000 population in Belgium to the lowest of 35.8 per 100,000 population in Iran, and the age‐standardized mortality from the highest of 41.0 per 100,000 population in Fiji to the lowest of 6.4 per 100,000 population in South Korea. The peak age of breast cancer in some Asian and African countries were over 10 years earlier than in European or American countries. As for the trends of breast cancer, the age‐standardized incidence rates significantly increased in China and South Korea but decreased in the United States of America (USA) during 2000‐2012. Meanwhile, the age‐standardized mortality rates significantly increased in China and South Korea but decreased in the United Kingdom, the USA, and Australia during 2000 and 2015. Conclusions The global burden of breast cancer is rising fast and varies greatly among countries. The incidence and mortality rates of breast cancer increased rapidly in China and South Korea but decreased in the USA. Increased health awareness, effective prevention strategies, and improved access to medical treatment are extremely important to curb the snowballing breast cancer burden, especially in the most affected countries.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mammographic density and the risk and detection of breast cancer.

              Extensive mammographic density is associated with an increased risk of breast cancer and makes the detection of cancer by mammography difficult, but the influence of density on risk according to method of cancer detection is unknown. We carried out three nested case-control studies in screened populations with 1112 matched case-control pairs. We examined the association of the measured percentage of density in the baseline mammogram with risk of breast cancer, according to method of cancer detection, time since the initiation of screening, and age. As compared with women with density in less than 10% of the mammogram, women with density in 75% or more had an increased risk of breast cancer (odds ratio, 4.7; 95% confidence interval [CI], 3.0 to 7.4), whether detected by screening (odds ratio, 3.5; 95% CI, 2.0 to 6.2) or less than 12 months after a negative screening examination (odds ratio, 17.8; 95% CI, 4.8 to 65.9). Increased risk of breast cancer, whether detected by screening or other means, persisted for at least 8 years after study entry and was greater in younger than in older women. For women younger than the median age of 56 years, 26% of all breast cancers and 50% of cancers detected less than 12 months after a negative screening test were attributable to density in 50% or more of the mammogram. Extensive mammographic density is strongly associated with the risk of breast cancer detected by screening or between screening tests. A substantial fraction of breast cancers can be attributed to this risk factor. Copyright 2007 Massachusetts Medical Society.
                Bookmark

                Author and article information

                Contributors
                sa92.mohammadi@gmail.com
                km_282@yahoo.com
                Journal
                J Med Radiat Sci
                J Med Radiat Sci
                10.1002/(ISSN)2051-3909
                JMRS
                Journal of Medical Radiation Sciences
                John Wiley and Sons Inc. (Hoboken )
                2051-3895
                2051-3909
                03 April 2024
                September 2024
                : 71
                : 3 ( doiID: 10.1002/jmrs.v71.3 )
                : 375-383
                Affiliations
                [ 1 ] Department of Medicine Hamadan University of Medical Sciences Hamadan Iran
                [ 2 ] Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine Tehran University of Medical Sciences Tehran Iran
                [ 3 ] Department of Medical Physics and Biomedical Engineering, School of Medicine Tehran University of Medical Sciences Tehran Iran
                [ 4 ] Department of Radiology, Faculty of Paramedical Sciences Kurdistan University of Medical Sciences Sanandaj Iran
                [ 5 ] Department of Radiation Oncology Hamadan University of Medical Sciences, Mahdieh Center Hamadan Iran
                Author notes
                [*] [* ] Correspondence

                Kamal Mohammadian, Department of Radiation Oncology, Hamadan University of Medical Sciences, Mahdieh Center, Hamadan, Iran. Tel: +98 81 8380044; fax: +98 81 38380044; E‐mail: km_282@ 123456yahoo.com

                Sana Mohammadi, Department of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran. Tel: +98 81 31310000; fax: +98 81 38382112; E‐mail: sa92.mohammadi@ 123456gmail.com

                Author information
                https://orcid.org/0000-0003-1334-8826
                Article
                JMRS788 JMRS-2023-179.R3
                10.1002/jmrs.788
                11569425
                38571377
                e0cf2d3d-5d08-455d-95ad-11011dab975c
                © 2024 The Authors. Journal of Medical Radiation Sciences published by John Wiley & Sons Australia, Ltd on behalf of Australian Society of Medical Imaging and Radiation Therapy and New Zealand Institute of Medical Radiation Technology.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 07 October 2023
                : 20 March 2024
                Page count
                Figures: 5, Tables: 3, Pages: 9, Words: 5979
                Categories
                Original Article
                Original Article
                Custom metadata
                2.0
                September 2024
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.1 mode:remove_FC converted:17.11.2024

                breast cancer,breast density,image processing,mammography,percent density,radiotherapy

                Comments

                Comment on this article